Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04077372 · ClinicalTrials.gov registry record · NA

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

A NA study, sponsored by Stanford University.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT04077372: Clinical Trial NA study, sponsored by Stanford University.

NCT04077372 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04077372, a NA study, was terminated before completion, sponsored by Stanford University.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.

Interventions

  • BEHAVIORAL Serious Illness Conversation Guide (SICG)
  • BEHAVIORAL Quality of Life (QOL) survey

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2019-09-16
Est. Completion 2020-10-11
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04077372

The ClinicalTrials.gov registry entry for NCT04077372 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Serious Illness Conversation Guide (SICG) is the first listed.

NCT04077372 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04077372 about?

NCT04077372 is a clinical study titled "Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers". The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.

What is the current status of trial NCT04077372?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-09-16. Estimated completion is 2020-10-11.

What interventions are being tested in trial NCT04077372?

The interventions under investigation include: Serious Illness Conversation Guide (SICG) (BEHAVIORAL), Quality of Life (QOL) survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT04077372?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.